Cedar Brook Financial Partners, LLC Thermo Fisher Scientific Inc. Transaction History

Cedar Brook Financial Partners, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$528.82 - $599.43 $13,220 - $14,985	25 Added 2.48%	1,035 $601,000
Q4 2023 Jan 12, 2024	BUY	$431.41 - $532.94 $167,387 - $206,780	388 Added 62.38%	1,010 $536,000
Q3 2023 Oct 17, 2023	SELL	$498.29 - $574.41 $39,364 - $45,378	-79 Reduced 11.27%	622 $314,000
Q2 2023 Jul 05, 2023	SELL	$508.46 - $591.13 $12,711 - $14,778	-25 Reduced 3.44%	701 $365,000
Q1 2023 Apr 04, 2023	BUY	$535.0 - $604.82 $12,840 - $14,515	24 Added 3.42%	726 $418,000
Q4 2022 Feb 01, 2023	SELL	$484.71 - $571.37 $9,209 - $10,856	-19 Reduced 2.64%	702 $386,000
Q3 2022 Jan 03, 2023	BUY	$507.19 - $604.49 $19,273 - $22,970	38 Added 5.56%	721 $365,000
Q2 2022 Aug 12, 2022	BUY	$500.9 - $612.21 $44,079 - $53,874	88 Added 14.79%	683 $371,000
Q1 2022 Apr 06, 2022	BUY	$524.0 - $644.92 $30,916 - $38,050	59 Added 11.01%	595 $351,000
Q4 2021 Jan 27, 2022	BUY	$569.0 - $667.24 $19,346 - $22,686	34 Added 6.77%	536 $357,000
Q3 2021 Nov 01, 2021	SELL	$509.53 - $609.78 $17,324 - $20,732	-34 Reduced 6.34%	502 $287,000
Q2 2021 Aug 16, 2021	BUY	$441.0 - $508.24 $18,963 - $21,854	43 Added 8.72%	536 $271,000
Q1 2021 May 11, 2021	SELL	$439.85 - $518.83 $2,639 - $3,112	-6 Reduced 1.2%	493 $225,000
Q4 2020 Feb 12, 2021	SELL	$435.06 - $527.66 $28,713 - $34,825	-66 Reduced 11.68%	499 $232,000
Q3 2020 Nov 09, 2020	SELL	$359.77 - $441.52 $1,439 - $1,766	-4 Reduced 0.7%	565 $249,000
Q2 2020 Aug 05, 2020	BUY	$275.2 - $362.34 $156,588 - $206,171	569 New	569 $206,000

2,829

334M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.